-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Oncotelic Therapeutics, Inc. annual/quarterly Amortization of Intangible Assets history and growth rate from Q2 2018 to Q3 2022.
- Oncotelic Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
- Oncotelic Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $12.8K, a 75% decline from 2021.
- Oncotelic Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $51.4K, a 84.3% decline from 2020.
- Oncotelic Therapeutics, Inc. annual Amortization of Intangible Assets for 2020 was $327K, a 536% increase from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)